Cargando…
Which Biomarker is the Best for Predicting Mortality in Incident Peritoneal Dialysis Patients: NT-ProBNP, Cardiac TnT, or hsCRP?: A Prospective Observational Study
Although numerous previous studies have explored various biomarkers for their ability to predict mortality in end-stage renal disease (ESRD) patients, these studies have been limited by retrospective analyses, mostly prevalent dialysis patients, and the measurement of only 1 or 2 biomarkers. This pr...
Autores principales: | Oh, Hyung Jung, Lee, Mi Jung, Kwon, Young Eun, Park, Kyoung Sook, Park, Jung Tak, Han, Seung Hyeok, Yoo, Tae-Hyun, Kim, Yong-Lim, Kim, Yon Su, Yang, Chul Woo, Kim, Nam-Ho, Kang, Shin-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915864/ https://www.ncbi.nlm.nih.gov/pubmed/26554763 http://dx.doi.org/10.1097/MD.0000000000001636 |
Ejemplares similares
-
NT-proBNP: Is It a More Significant Risk Factor for Mortality Than Troponin T in Incident Hemodialysis Patients?
por: Oh, Hyung Jung, et al.
Publicado: (2014) -
Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea
por: Lee, Mi Jung, et al.
Publicado: (2016) -
Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP
por: Bissell, Lesley-Anne, et al.
Publicado: (2019) -
Association of NT-proBNP and hs-cTnT with Imaging Markers of Diastolic Dysfunction and Focal Myocardial Fibrosis in Hypertrophic Cardiomyopathy
por: Chevalier, Céleste, et al.
Publicado: (2022) -
Prooxidant–antioxidant balance, hsTnI and hsCRP: mortality prediction in haemodialysis patients, two-year follow-up
por: Antunovic, Tanja, et al.
Publicado: (2017)